LAUREN BROCK: Open Payments
NPI 1427435643 · NORTHPORT, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$234 in 13 payments from 8 companies in 2025. Trend: 2023 $37 · 2024 $236 · 2025 $234
Food & beverage: $234
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $39 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| Dexcom, Inc. | 2 | $36 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
| Abbott Laboratories | 1 | $19 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Corium, LLC | 1 | $17 |
Products named: Ozempic, FARXIGA, NEXLETOL, Dexcom G6 Transmitter, GVOKE HYPOPEN, ETERNA, INSPIRE, Azstarys.
Industry payments across AL — which companies pay providers there.
